Lisinopril's Renoprotective Effects in Chronic Kidney Disease

Mechanisms of Kidney Protection

The renoprotective effects of lisinopril appear to be greater than what would be expected from blood pressure reduction alone, suggesting additional protective mechanisms 1

In patients with type 2 diabetes and macroalbuminuria, ACE inhibitors like lisinopril slow the decline in glomerular filtration rate (GFR) and delay onset of kidney failure 1, 3
The KDOQI guidelines strongly recommend (1B) starting ACE inhibitors like lisinopril in patients with diabetes, CKD, and moderate to severely increased albuminuria (categories A2 and A3) 3
For non-diabetic CKD patients with severely increased albuminuria (≥300 mg/24h), ACE inhibitors like lisinopril are strongly recommended even without hypertension 2
In patients with moderately increased albuminuria (30-300 mg/24h) without diabetes, lisinopril is suggested as a treatment option (weaker recommendation 2C) 3

When initiating lisinopril, serum creatinine and potassium should be checked within 2-4 weeks to monitor for potential adverse effects 2
Avoid combining lisinopril with other RAS blockers (ARBs or direct renin inhibitors) as this increases adverse effects without additional benefit 3, 2

For optimal kidney protection, target blood pressure should be <120 mmHg systolic in most CKD patients, which may require combination therapy 4
Diuretics may potentiate the beneficial effects of lisinopril in hypertensive patients with diabetic kidney disease 1

Lisinopril may cause an initial decrease in GFR that stabilizes over time; this should not necessarily prompt discontinuation unless the decline exceeds 30% 2
Temporary reduction or holding of lisinopril doses is recommended during periods of decreased oral intake, vomiting, or diarrhea to prevent acute kidney injury 2